Clinical Trials on Refractory Waldenstrom Macroglobulinemia
Total 3001 results
-
Genesis Pharma S.A.Completed
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Vanderbilt UniversityCompletedCervical Dystonia | Refractory Cervicothoracic Myofascial Pain Syndrome (CMPS)United States
-
Mayo ClinicCompletedMultiple Myeloma | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Small Lymphocytic Lymphoma | B-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Roswell Park Cancer InstituteWithdrawnRefractory Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia
-
City of Hope Medical CenterCompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
University of California, San FranciscoCompletedClinically Severe Obesity | Obesity Recidivism | Inadequate Initial Weight Loss | Poor Weight Loss | Persistent Obesity | Refractory Obesity | Intractable ObesityUnited States
-
Fachklinik Hornheide an der Universität MünsterUnknownAdvanced Metastastic Malignant Melanoma | Refractory to First-Line Chemotherapy Irresectable Progressive Soft Tissue MetastasesGermany
-
Beijing GoBroad HospitalRecruitingAcute Lymphoblastic Leukemia, in Relapse | Refractory Acute Lymphoblastic Leukemia | T-cell Acute Lymphoblastic LeukemiaChina
-
Beijing Yongtai Ruike Biotechnology Company LtdRecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-cell LymphomaChina
-
RenJi HospitalRecruitingDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B Cell Lymphoma RefractoryChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
Mayo ClinicRecruitingRecurrent Chronic Myelomonocytic Leukemia | Refractory Chronic Myelomonocytic LeukemiaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Cullinan Oncology Inc.RecruitingMyelodysplastic Syndrome (MDS) | Relapsed/Refractory Acute Myeloid Leukemia (AML)United States
-
Mehrdad Abedi, MDNational Cancer Institute (NCI)RecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
Emory UniversityNational Cancer Institute (NCI); Novartis; Secura Bio, Inc.RecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
WepromRecruitingDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaFrance
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingRefractory T Acute Lymphoblastic Leukemia | Recurrent T Acute Lymphoblastic LeukemiaUnited States
-
Seoul National University HospitalNot yet recruitingDiffuse Large B Cell Lymphoma | Refractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaKorea, Republic of
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Dana-Farber Cancer InstituteBayer; AbbVieActive, not recruitingDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States
-
Newave Pharmaceutical IncActive, not recruitingRefractory Acute Lymphoblastic Leukemia | Relapse | CMML | Relapsed Adult AML | AML/MDS | Relapse LeukemiaUnited States, Spain
-
Kartos Therapeutics, Inc.TerminatedRelapsed or Refractory Acute Myeloid Leukemia (AML) | Acute Myeloid Leukemia (AML), Secondary to Myeloproliferative Neoplasms (MPN)United States, Spain, Korea, Republic of, Belgium, United Kingdom, Hungary, France, Germany, Israel, Australia, Italy, Poland
-
Alexion Pharmaceuticals, Inc.No longer availableNon-hodgkin's Lymphoma | Relapsed/Refractory Chronic Lymphocytic Leukemia
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Plasma Cell NeoplasmUnited States
-
Centre for Addiction and Mental HealthNational Institute of Mental Health (NIMH)Active, not recruitingDepression | Dementia | Mild Cognitive Impairment | Major Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
AmgenMerck Sharp & Dohme LLCCompletedRelapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)United States, Germany, Spain, Australia, Netherlands, France
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Juno Therapeutics, Inc.CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
ADC Therapeutics S.A.CompletedDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B-Cell Lymphoma RefractoryUnited States, United Kingdom, Italy, Switzerland
-
University of Southern CaliforniaNational Cancer Institute (NCI); Oncolytics BiotechCompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Fondazione Italiana Linfomi ONLUSJanssen Pharmaceutica; Janssen-Cilag Ltd.; Centro di Riferimento per l'Epidemiologia...CompletedDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B-cell Lymphoma RefractoryItaly
-
Opna-IO LLCCompletedHigh-risk Myelodysplastic Syndrome (MDS) | Relapsed Acute Myeloid Leukemia (AML) | Refractory Acute Myeloid Leukemia (AML)United States
-
Roswell Park Cancer InstituteCelgeneWithdrawnRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | IDH2 Gene Mutation | Blasts Under 5 Percent of Peripheral Blood White Cells | Bone Marrow Blasts Decreased by 50 Percent or More Compared to Pretreatment LevelUnited States
-
Medical College of WisconsinWithdrawnRefractory Multiple Myeloma | Relapse Multiple Myeloma
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States, Italy
-
Yvonne EfeberaBristol-Myers Squibb; National Cancer Institute (NCI); American Cancer Society...TerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRefractory Childhood Hodgkin Lymphoma | Ann Arbor Stage I Childhood Hodgkin Lymphoma | Ann Arbor Stage II Childhood Hodgkin Lymphoma | Ann Arbor Stage III Childhood Hodgkin Lymphoma | Ann Arbor Stage IV Childhood Hodgkin LymphomaUnited States, Canada, Australia, Switzerland
-
Cleave Biosciences, Inc.TerminatedLymphoid Hematological Malignancies | Relapsed and Refractory Multiple MyelomaCanada, United States